Literature DB >> 11421633

A bihormonal model of normal sexual stimulation; the etiology of premature ejaculation.

I G Motofei1.   

Abstract

The physiological sexual excitation is mediated both by the sympathetic and the parasympathetic nervous system. The antagonism between testosterone (Tt) and estrogens (Es) as well as the fact that the dynamics of the sexual excitation in the male are antagonistic to those in the female are nowadays well-known; hence, the hypothesis was emitted that the sympathoparasympathetic sexual excitation is bihormonal mediated, consisting in a very active sexual hormone associated with a weak antagonistic hormone. Most studies show a serotonergic (ejaculatory) involvement in premature ejaculation (PE). Nevertheless, an effective treatment of PE is rather difficult with selective serotonin reuptake inhibitor drugs and other clinical data even suggest that changes in PE actually involve at first the sexual excitation process and only secondly the ejaculation reflex.Thus, a therapeutic model for PE is set up, starting from the physiological aspects described and from the presumed pathophysiological mechanism in PE. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421633     DOI: 10.1054/mehy.2001.1296

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Testosterone relaxes rabbit seminal vesicle by calcium channel inhibition.

Authors:  Jong Kok Kim; Woo Ha Han; Moo Yeol Lee; Soon Chul Myung; Sae Chul Kim; Min Ky Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-04-30       Impact factor: 2.016

2.  Clinical study on the treatment of premature ejaculation by Uighur medicine gu-jing-mai-si-ha tablet.

Authors:  Guo-hong Song; Jin-cheng Geng; Lian-cheng Feng; Chao Ma; Jun Liu
Journal:  Chin J Integr Med       Date:  2007-09       Impact factor: 1.978

3.  Prevalence of erectile and ejaculatory difficulties among men in Croatia.

Authors:  Aleksandar Stulhofer; Zarko Bajić
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.